AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2018
Jan 25, 2018
34129_dirs_2018-01-25_04eb1d19-4086-4c1c-aece-91f0d493c8a3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2018-01-24
Reporting Person: Risser Eric Blasius (Sr VP & Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-24 | Common Stock | M | 3000 | $0.94 | Acquired | 12100 | Direct |
| 2018-01-24 | Common Stock | S | 3000 | $22.50 | Disposed | 9100 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-24 | Employee stock option (right to buy) | $0.94 | M | 3000 | Disposed | 2019-03-23 | Common Stock (3000.0) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted 11/14/17.
F2: This transaction was executed in multiple trades at prices ranging from $20.50 to $20.51.
More from MACROGENICS INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18